NEW YORK, June 30 (GenomeWeb News) - Genedata today said that the Novartis Institute for Tropical Diseases in Singapore will use its Phylosopher PathoLead software to study progressive infectious and parasitic disease.
Specifically, the Phylosopher software will serve as an organization-wide scientific management system for proprietary data integration.
Scientists at NITD will use the software to identify and validate target candidates and prioritize the development of drug classes. Research at NITD focuses on Dengue fever and tuberculosis. The ultimate goal would be to develop an anti-viral treatment, the group said.
Almost exactly two years ago, Basel, Switzerland-based Genedata licensed the PathoLead suite of tools to Novartis' Institutes for BioMedical Research.